Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am buying more at these levels....
Big Y, One of the Largest Supermarket Chains in the Northeast, to Sell Else Kids Nutrition Products
Friday, April 8, 2022, 7:00 AM ET
Following the company's business strategy and the success of Else Toddler Nutrition launch at Big Y, its plant-based kids' shakes products will be available in more than 70 new locations in New England
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), the Plant-Based baby, toddler, and children nutrition company, today announced that following the successful launch and performance of Else Toddler Nutrition, retailer Big Y will be adding two additional products -- Else Plant-Based Kids Shakes, in chocolate and vanilla flavors, at all locations. The products are expected to hit the shelf in Q2 and extend the ' 'brand's shelf presence and offerings of its Clean Label certified, whole Plant-Based nutrition into the kids' segment.
Made from whole food, clean ingredients, including organic almonds, buckwheat, and tapioca, which account for over 90 percent of the ingredients, Else Complete Nutrition Shakes for Kids are packed with nutrients, free from dairy, soy, gluten, and contain 50 percent less sugar than other options available in the market. The products are specially designed to help support the growth and development of children.
Since launching its Plant-Based Complete Nutrition for Toddlers, which won the Good Housekeeping Parenting Award for 2021, the brand has received powerful testimonials and reviews from moms. Else Toddler Nutrition was also awarded "Best dairy alternative" at World Plant-Based Expo in December of 2021. It was also a finalist at the Nexty Awards at Expo West 2022.
Who cares..it's irrelevant.....just because a print goes through..and you try to assign some logic to it..doesn't mean anything...or that it's even logical
Just human nature to try and make sense out of something where there is nothing but nonsense.
Move on...this is done.
I agree and have posted this repeatedly..no one listens..so a waste of time here...
An elaborate scam.....nothing more...nothing less.
Play the price action and not the bs from the company..otherwise you become a bagholder...fact is..the majority of companies trading on the otc are scams..and this is but another one...just look at the history...it's laughable.
Total and complete garbage......just another pinky enticing with bs and lies and removing investors from their money..stay away.
In your opinion.....which is worth what?
LOL...this is as dead as John Lennon.
Same bs..still going on..wait for the podcast..lol
It was stupid 2 years ago...that's when I bailed...
The tablet?..what tablet?...
There are several other tablets already on the market in stronger strengths..I have no clue what you are alluding to...
But do a little dd..and you will soon realize that Panaxia..Canntab..just 2 companies of many for example that have surpassed anything OW may have ever attempted...
I am wondering if what you wrote was sarcasm because otherwise...I don't know what to say.
OWC is dead and done....when will that sink in.
I have been here in one form or another since late 2016...
LOL
What lawsuit are you talking about?
There is no lawsuit...duh.
https://www.prnewswire.com/news-releases/if-you-purchased-owc-pharmaceutical-research-corp-stock-between-november-2016-and-september-2017-you-may-be-eligible-for-distribution-from-the-jeffrey-friedland-fair-fund-301471030.html
https://www.jeffreyfriedlandfairfund.com/
The company will be just fine doing what they're doing.
This is and always has been the bell weather of the company.
FDA Update
In Q4 2021 Else concluded a successful preclinical safety study on its plant-based infant formula, as part of the pathway to bring its Infant formulation to market.
The study results demonstrated proper growth, similar to dairy-based infant formula, in a neonatal preclinical model, which is a key first step on the path with the US Food and Drug Administration (FDA), as well as with other regulatory authorities, to demonstrate safety and nutrient bioavailability of the infant formula and its ingredients. The study results will be presented in two key scientific meetings focused on pediatric nutrition and will be published in scientific peer-reviewed journals. Else is in close communication with the FDA, sharing its plans and results to receive their guidance throughout the process of Else’s infant formula development. Else also worked on preparations for the three clinical studies planned for 2022. In 2022 we plan to continue our research activity demonstrating the safety of the infant formula as well as provide scientific support for our products including preparations for additional clinical studies.
Latest powerpoint deck on Else Nutrition...
Lot's to be excited about!!!!
https://kvisit.com/Og/u4oE
And it continues....
Else making a nice move up....
Else Nutrition Launches Toddler Omega Complete & Balanced That Will Sell First on Amazon.com & Elsenutrition.com in the Coming Weeks, Followed by Retail Distribution
Tuesday, March 22, 2022, 7:00 AM ET
On the Heels of the Strong Success of the Original Organic Toddler Product, to address a wider target market and maximize its reach
VANCOUVER, British Columbia, March 22, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler and children nutrition company, is pleased to announce that is it set to launch Else(TM) Toddler Omega complete & balanced nutrition drink in the coming weeks on Amazon.com and soon after on the Company's e-store. This will be followed by retail distribution in select retail outlets.
Following the success of strong market response to its Organic Plant-Based Complete Nutrition for Toddlers, the Company has formulated Else(TM) Toddler Omega, its first toddler product to have added Omega 3 and Omega 6 fatty acids that support brain and eye development, designed to optimize essential proteins, making it complete and balanced.
"We're thrilled to build on the success of our flagship Organic Toddler product, with a new offering that addresses a larger audience. We're continually innovating to respond to customers' requests and pediatricians' expectations, and this offering is expected to further expand the size and growth rate of our Toddler-targeted business," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition.
With essential Omega 3 & 6 for brain development, high quality Plant-Based protein from almonds, buckwheat and supplemented with additional free amino acids and over 20+ vitamins and minerals, Else(TM) Toddler Omega is a complete and balanced plant-based, clean-label, non-GMO, soy-free, gluten-free, non-organic nutritional drink for toddlers aged 12-36 months. It is designed to support a toddler's growth and development, as well as promote natural digestion, through its combination of whole food ingredients: almond, buckwheat, and tapioca.
The new product will be offered in 22oz powder cans at a price of $29, to address a wider target market and to maximize its reach. It will be available in multiple formats (single, 2-pack and 4-pack). The product has also received the Clean Label Purity Award Certification, attesting to its quality for meeting the rigorous standards of the Clean Label Projects, which tests products for over 400 impurities including heavy metals, pesticides, and many other contaminants.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The Company recently received the World Plant-Based Award for "Best dairy alternative product" in New York at World Plant-Based Expo in late 2021. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else's Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/563ecd56-e5ef-4bea-9e41-f1e58a86dea9
Investor Relations Contact:
Lytham Partners, LLC
Mr. Ben Shamsian
New York | Phoenix
E: shamsian@lythampartners.com
P: 646-829-9701
LOL..it's been over for a very long time...
NO that's not what happened at all..lol
Read my posts..I said all the court action was bs...and guess what...it was.
Hey Phoenix..when are the courts going to rule..
You are not considered an alien...fill out the proper forms for foreign holders as best you can...if in doubt call and speak with an agent....
If you have questions not answered through this website, you may contact the Distribution Agent toll-free at 1-877-379-5985, by email at info@jeffreyfriedlandfairfund.com, or by mail at:
Jeffrey Friedland Fair Fund
c/o JND Legal Administration
PO Box 91436
Seattle, WA 98111
The market has not recovered..is not recovering....oil is up because of the crisis..gold and commodities are up....for the same reason but overall...stocks are down and not moving in either direction for the most part....or moving to the downside.....
https://www.theguardian.com/business/2022/mar/04/ukraine-war-a-catastrophe-for-global-economy-as-stock-markets-plunge
https://www.cnbc.com/2022/03/03/ukraine-news-retailers-start-warn-of-business-impact-from-russian-invasion.html
https://welchgroup.com/what-should-you-do-about-the-russia-ukraine-crisis-and-market-volatility/
The bs is astounding.
The 3.23 high was most definitely during the claim period of 11/18/16-9/22/17....As you stated the 3.23 occurred on 2/22/17..How is that not during the claim period?
Yes..we do..it just becomes a little tricky when filling out the forms as they are based on US tax laws and don't pertain to Canadians for example...
I have spoken to an agent at the administration of the fund 2 times and they told me that the most important thing is to have your trading records to back up your claim.
She told me to fill out the forms as best I could and anything concerning US tax forms..just ignore as US tax rules won't apply to foreign holders of the OTC stock OWCP.
The company isn't only depending on the OTC to lift the CE...they have a plan "B".... Hopefully they won't have to go that route...whatever it is...
It would be pure folly to think Michael isn't exploring other options to circumvent the BS from the OTC Markets Group.
Thanks for the clarification.....others don't see it that way and continue to tout opinions as fact.
But the fact is..he mentioned Regen 2 days ago in his tweet.
I am so tired of opinions being stated as facts.
Explain to me if you're willing how Ichim is only hyping his work if he directly mentions Regen in his tweet......
Else Nutrition
Behind the headlines on baby food purity and heavy metal contaminants is true cause for concern. We’re parents too, and we understand. That’s why we’re bringing the first and only Clean Label Project Certified Baby Cereal to the U.S. market – coming next month!
We’re bringing the Clean Movement to you. After all, you’re the parents demanding better for your little ones. Let us join you in the call to change the status quo from questionable to clean.
4CABLE TV INTERNATIONAL, INC. ANNOUNCES CONVERSION OF PREFERRED B SHARES TO COMMON STOCK AND OTHER DEBT CONVERSION; AND PETITIONING FOR THE REMOVAL OF THE CE DESIGNATION
March 01 2022 - 08:00AM
InvestorsHub NewsWire
Miami, FL -- March 1, 2022 -- InvestorsHub NewsWire -- 4Cable TV International, Inc. (OTC: CATV) (the "Company") CATV: A group oriented to become a global leader in Cannabis based products markets.
The Company is pleased to announce that all its outstanding convertible notes, and all amounts due thereunder with Marquis Trading, LLC have been settled and released. These debts were resolved with no dilution of the stock. Marquis Trading, LLC now has no connection to the company whatsoever, and will never become a shareholder of the company by virtue of the conversion of such notes.
CONVERSIONS
On January 29, 2022 all Preferred B Shares of the company were registered within the framework of the Company's transfer agent.
After the one-year anniversary from the acquisition of Healthcare and Wellness Clinics of America and Corporation Clinic, the Preferred B shareholders have converted their shares into common stock making the transaction final. The new common shareholders include Central Health and Innovation, LLC, partly owned by the CEO, Michael Feldenkrais, and the remainder was issued to KK Family Investments, LLC. The total shares issued for the conversion from the 2,058 Preferred B shares issued for the acquisition of Healthcare and Wellness Clinics of America and Corporation Clinic resulted in the conversion to 514,705,882 common shares. Of these, Central Health and Innovation, LLC received 185,294,117 common shares and KK Family Investments, LLC received 329,411,765 common shares.
The $375,000 in promissory notes that were also part of the purchase price of that transaction, were likewise converted into common shares. The shares were converted at a market price resulting in the issuance an additional 144,440,408 common shares. Of these, Central Health and Innovation, LLC received 51,998,547 common shares while, KK Family Investments, LLC received 92,441,861 common shares.
Further to conversions of other debts owed by CIGN, LLC to third parties, additional common shares were issued subject to the applicable provisions of Rule 144. The total conversion of debt from CIGN, LLC to common shares of the Company amounted to 104,222,516 common shares in exchange for release of debt of $511,714.00.
PETITION TO REMOVE CE DESIGNATION
On Friday February 24, 2022, the Company petitioned the OTC Markets Group ("OTC") to consider the removal of the Caveat Emptor designation from the Company's common shares. The Company believes that it presented a valid and compelling case for the removal of that designation and is cautiously optimistic of OTC's response.
UPDATES ON ACTIVITY
Hip Wynwood, a healthy oriented restaurant has opened its doors and will soon announce a grand opening event. The CIGN farm is under construction and the roofs have been partially installed and will be done shortly. We are getting ready to finish construction and begin operating again within the next month or so.
The Company is on track to file its annual report for the year ended December 31, 2021 on a timely basis and will continue to do its best efforts to move this company in the right direction.
ABOUT 4CABLE TV INTERNATIONAL, INC.
4Cable TV International, Inc. (OTC: CATV) (the "Company") seeks to create and operate a fully integrated global cannabis business, ranging from Seed to Sale.
Cautionary Note Regarding Forward-Looking Statements
Statements in this press release regarding 4Cable TV International's business that are not historical facts are "forward-looking statements." Examples of forward-looking statements include, among others, statements regarding the Company's future business and prospects, strategic plans, and strategic transactions and past results should not be construed as indicative of future performance. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations, and assumptions regarding the future of its business, future and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company's control. The Company's actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others: general economic and financial conditions; consumer demand for Cannabis products and services; volatility in the trading markets and the lack of liquidity in the Company's common stock; the Company's ability to successfully execute on its new Cannabis strategy; the Company's limited operating history in the Cannabis business; the legal status of the Company's Cannabis business, both in the U.S. and abroad; risks inherent in the Cannabis business; existing and new U.S. and foreign government regulations and changes in regulatory requirements; risks related to rules and regulations at the U.S. federal, state and municipal levels and applicable foreign jurisdictions with respect to Cannabis; the Company's ability to obtain financing or raise capital on favorable terms or at all in order to execute its business strategy; the Company's ability to successfully identify and integrate acquired businesses; risks associated with conducting operations in foreign countries; and risks associated with engaging in transactions with third parties, including related parties. For a discussion of additional general risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see the Company's OTC Market filings. Any forward-looking statement made by in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether because of new information, future developments or otherwise, except as required by law.
Company: CATV
Phone:1.833.211.3200
Location: Miami, FL
Email: info@4cabletvint.com
Website: www.4cabletvint.com
All opinion..no fact....that's what goes on here.
Call the number and speak to an agent.....wouldn't you rather ask them directly?
I just spoke with an administrator from the JND company that is looking after the Jeffrey Friedland Fair fund disbursement.
Everyone that has sent in a claim will receive notification with either a claim number or an explanation as to why their claim was not allowed and/or if there are documents or verification still needed in order to validate your claim.
The deadline to file is in June....and I was told today there are still over 100 claims that still need to be processed.
Stay tuned and if you have questions you can speak to an agent. (877) 379-5985 or via email....info@jeffreyfriedlandfairfund.com
Thanks for the explanation....
Not what I remember...at all.
But whatever.
I am only in to make a few ticks up then I am out...
I really could care less what this company does or what comes out of Koo's mouth and brain.
Ltr.
As I pointed out..it's not relevant here..so most are not interested in this bs.